WO1996038183A1 - Contrast medium and its use - Google Patents
Contrast medium and its use Download PDFInfo
- Publication number
- WO1996038183A1 WO1996038183A1 PCT/US1996/007666 US9607666W WO9638183A1 WO 1996038183 A1 WO1996038183 A1 WO 1996038183A1 US 9607666 W US9607666 W US 9607666W WO 9638183 A1 WO9638183 A1 WO 9638183A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cells
- contrast medium
- protecting
- agent
- contrast
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
- A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
- A61K49/0452—Solutions, e.g. for injection
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Food Science & Technology (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU59309/96A AU707118B2 (en) | 1995-05-31 | 1996-05-24 | Contrast medium and its use |
EP96916620A EP0863770A4 (en) | 1995-05-31 | 1996-05-24 | Contrast medium and its use |
US08/952,954 US6149891A (en) | 1995-05-31 | 1996-05-24 | X-ray contrast medium and method for protecting against harmful effects thereof |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL11392695A IL113926A (en) | 1995-05-31 | 1995-05-31 | Contrast medium with improved patient's tolerance thereto and its use |
IL113926 | 1995-05-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1996038183A1 true WO1996038183A1 (en) | 1996-12-05 |
Family
ID=11067540
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1996/007666 WO1996038183A1 (en) | 1995-05-31 | 1996-05-24 | Contrast medium and its use |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0863770A4 (en) |
AU (1) | AU707118B2 (en) |
CA (1) | CA2222429A1 (en) |
IL (1) | IL113926A (en) |
WO (1) | WO1996038183A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9066990B2 (en) | 2001-03-26 | 2015-06-30 | Bayer Intellectual Property Gmbh | Preparation for restenosis prevention |
US9649476B2 (en) | 2002-09-20 | 2017-05-16 | Bayer Intellectual Property Gmbh | Medical device for dispersing medicaments |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE34077E (en) * | 1988-05-02 | 1992-09-22 | Cryomedical Sciences, Inc. | Blood substitute |
US5199951A (en) * | 1990-05-17 | 1993-04-06 | Wayne State University | Method of drug application in a transporting medium to an arterial wall injured during angioplasty |
US5334370A (en) * | 1993-02-04 | 1994-08-02 | Sterling Winthrop Inc. | Compositions of alkylbenzenes in film-forming materials for visualization of the gastrointestinal tract |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2191118A (en) * | 1937-06-03 | 1940-02-20 | Firm Of N V Orgachemia | Pyelographic preparation |
US2870063A (en) * | 1955-07-05 | 1959-01-20 | Mallinckrodt Chemical Works | X-ray contrast composition comprising substantially amylose-free amylopectin in aqueous solution of contrast agent |
US3984571A (en) * | 1970-03-10 | 1976-10-05 | E. R. Squibb & Sons, Inc. | Hydrocolloid containing liquid carrier for a diagnostic or therapeutic agent |
US5847009A (en) * | 1986-01-14 | 1998-12-08 | Alliance Pharmaceutical Corp. | Prophylaxis in the parenteral administration of particulate dispersions in fluorocarbon emulsions |
FR2635327B1 (en) * | 1988-08-10 | 1990-11-16 | Guerbet Sa | IODINE POLYMERS WITH DEXTRAN SKELETON, METHODS OF PREPARING THEM AND APPLICATIONS THEREOF AS CONTRAST PRODUCTS |
US5019370A (en) * | 1989-07-10 | 1991-05-28 | University Of Kentucky Research Foundation | Biodegradable, low biological toxicity radiographic contrast medium and method of x-ray imaging |
DE19518221A1 (en) * | 1995-05-10 | 1996-11-14 | Schering Ag | Use of non-steroidal anti-inflammatories to improve the physiological tolerance of particulate pharmaceutical preparations |
-
1995
- 1995-05-31 IL IL11392695A patent/IL113926A/en not_active IP Right Cessation
-
1996
- 1996-05-24 CA CA002222429A patent/CA2222429A1/en not_active Abandoned
- 1996-05-24 AU AU59309/96A patent/AU707118B2/en not_active Ceased
- 1996-05-24 WO PCT/US1996/007666 patent/WO1996038183A1/en not_active Application Discontinuation
- 1996-05-24 EP EP96916620A patent/EP0863770A4/en not_active Withdrawn
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE34077E (en) * | 1988-05-02 | 1992-09-22 | Cryomedical Sciences, Inc. | Blood substitute |
US5199951A (en) * | 1990-05-17 | 1993-04-06 | Wayne State University | Method of drug application in a transporting medium to an arterial wall injured during angioplasty |
US5334370A (en) * | 1993-02-04 | 1994-08-02 | Sterling Winthrop Inc. | Compositions of alkylbenzenes in film-forming materials for visualization of the gastrointestinal tract |
Non-Patent Citations (2)
Title |
---|
BRITISH MEDICAL BULLETIN, Volume 50, Number 4, issued October 1994, VERSTRAETE, "Primary and Secondary Prevention of Arterial Thromboembolism", pages 946-965. * |
See also references of EP0863770A4 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9066990B2 (en) | 2001-03-26 | 2015-06-30 | Bayer Intellectual Property Gmbh | Preparation for restenosis prevention |
US9649476B2 (en) | 2002-09-20 | 2017-05-16 | Bayer Intellectual Property Gmbh | Medical device for dispersing medicaments |
Also Published As
Publication number | Publication date |
---|---|
EP0863770A1 (en) | 1998-09-16 |
IL113926A (en) | 2000-06-01 |
IL113926A0 (en) | 1995-08-31 |
AU5930996A (en) | 1996-12-18 |
CA2222429A1 (en) | 1996-12-05 |
AU707118B2 (en) | 1999-07-01 |
EP0863770A4 (en) | 2001-01-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100874308B1 (en) | Formulations for preventing restenosis | |
Strömqvist | Femoral Head Vitality After Intracapsular Hip Fracture: 490 Cases Studied by Intravital Tetracyche Labeling and Tc-MDP Radionuclide Imaging. | |
Binning et al. | Rathke cleft cyst intracystic nodule: a characteristic magnetic resonance imaging finding | |
US9114162B2 (en) | Loadable polymeric particles for enhanced imaging in clinical applications and methods of preparing and using the same | |
IE66694B1 (en) | Chelate compositions | |
Yildirgan et al. | Intrabiliary rupture in liver hydatid cysts: results of 20 years’ experience | |
US6149891A (en) | X-ray contrast medium and method for protecting against harmful effects thereof | |
Böckler et al. | Endoluminal stent-graft repair of aortobronchial fistulas: bridging or definitive long-term solution? | |
AU707118B2 (en) | Contrast medium and its use | |
EP1411992B1 (en) | Ionic and non-ionic radiographic contrast agents for use in combined x-ray and nuclear magnetic resonance diagnostics | |
Amar et al. | Percutaneous carotid angioplasty and stenting with the use of gadolinium in lieu of iodinated contrast medium: technical case report and review of the literature | |
Trebše et al. | Chondroblastoma of the patella associated with an aneurysmal bone cyst | |
Matsuura et al. | A case report of venous aneurysm of the neck vein | |
Maurer et al. | Hepatic artery embolisation with a novel radiopaque polymer causes extended liver necrosis in pigs due to occlusion of the concomitant portal vein | |
BJÖRK et al. | A new type of contrast medium in arthrography | |
JPH05246896A (en) | Composition for contrastradiography of digestive tract | |
Biyase | Contrast and dyes | |
Kayaoglu et al. | Surgical treatment of symptomatic cavernous hemangiomas of the liver | |
Trinidad et al. | Perigraft air mimicking infection on CT angiography following open abdominal aortic aneurysm repair | |
EP2214718A1 (en) | Loadable polymeric particles for enhanced imaging in clinical applications and methods of preparing and using the same | |
Vigneron et al. | Complete and partial ureteral obstruction: evaluation of renal effects with P-31 MR spectroscopy and Tc-DMSA scintigraphy. | |
Jenner et al. | Hepatobiliary imaging: a comparison of 99Tcm-dihydrothioctic acid and 99Tcm-pyridoxylidene glutamate in the non-jaundiced patient | |
Arruda-Sanchez et al. | Preliminary results from clinical application of a natural oral contrast agent in magnetic resonance imaging (MRI) of the gastrointestinal (GI) system | |
GB2465663A (en) | X-ray contrast agent compositions comprising an iodinated X-ray contrast agent and ethylenediamine-N,N-disuccinic acid | |
Lee et al. | The Apoptotic Effect of Radiocontrast Media on Human Umbilical Vein Endothelial Cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 08952954 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref document number: 2222429 Country of ref document: CA Ref country code: CA Ref document number: 2222429 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1996916620 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 1996916620 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1996916620 Country of ref document: EP |